Recent blog posts
The Dual Boom of Bispecific Antibodies: Market and Drug Discovery Pipeline
Advanced Tech.
6 min read
The Dual Boom of Bispecific Antibodies: Market and Drug Discovery Pipeline
18 July 2023
They have gained broad potential in preclinical and clinical investigations in a variety of tumor types following regulatory approval of newly developed technologies involving bispecific and multispecific antibodies.
Read →
Organoid-On-Chips: A Potential Game Changer for Clinical Studies
Advanced Tech.
5 min read
Organoid-On-Chips: A Potential Game Changer for Clinical Studies
12 July 2023
HRS-1893 works through a special mechanism that inhibits myocardial excessive contraction and is intended for the treatment of hypertrophic cardiomyopathy and heart failure caused by myocardial hypertrophy.
Read →
The Magic Bullets of Cancer Treatment: ADCs and Their Journey from Concept to Clinic
Advanced Tech.
5 min read
The Magic Bullets of Cancer Treatment: ADCs and Their Journey from Concept to Clinic
11 July 2023
Unlike conventional chemotherapy, which can damage healthy cells, ADCs are intended to target and kill tumor cells while sparing healthy cells.
Read →
Small Nucleic Acid Drugs: Under the Spotlight, Surging Waves
Advanced Tech.
8 min read
Small Nucleic Acid Drugs: Under the Spotlight, Surging Waves
7 July 2023
What are small nucleic acid drugs, and why are they highly valued by industry giants?
Read →
mRNA Vaccines: Embracing Change and Moving Forward
Advanced Tech.
5 min read
mRNA Vaccines: Embracing Change and Moving Forward
28 June 2023
mRNA vaccines involve delivering mRNA encoding antigen proteins into the human body, which is then translated directly into antigens, inducing an immune response.
Read →